Downregulation of GLS, GOT2, and ASNS effectively blocks SOX12-mediated CRC cell proliferation and metastasis, while ectopic expression of these enzymes reverses the inhibitory effects of SOX12 knockdown on tumor progression (36). This evidence concerns the gene GOT2 and colorectal carcinoma.